Abstract
Attention-deficit/hyperactivity disorder (ADHD) affected approximately 4% to 12% of children worldwide. Although numerous ADHD medications approved by the FDA, off-label prescribing is quite common. However, the risk and benefit of off-label drug use remain controversial especially for children. The study aimed to investigate the factors and patterns of off label prescribing in Children with ADHD.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
